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The biotin analogue biotinylglycyltyrosine has been synthesized and labelled to a specific activity of 2000 
Ci/mmol with iz51. This analogue has been used in conjunction with immobilized streptavidin in an assay 
which detects as little as 1 fmol biotin or biotinylated molecules in solution. The determination of biotinylat- 
ed insulin in a tissue extract and the quantitation of a transcription assay are given as examples. 
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1. INTRODUCTION 
We found it necessary to assay for femtomolar 
amounts of biotinylated compounds in solution. 
Although 1251 labelled avidin and streptavidin are 
frequently used as probes for the presence of 
biotinylated molecules, particularly after Western 
blotting, no routine quantitative assay is available 
for the detection of sub-picomolar amounts of 
biotinylated molecules in solution. Fluorimetric 
methods detect at most 100 pmol in solution [l], 
and are not always useful for detecting biotin 
derivatives. 14C- or 3H-labelled biotin isotope dilu- 
tion assays can detect at best 1 pmol of unlabelled 
biotin [2,3]. Charcoal adsorption assays [4] are not 
useful for detecting biotinylated molecules which 
are likely to be adsorbed by charcoal. Solid-phase 
assays using immobilized avidin and ‘H- or 14C- 
labelled biotin have been described [5,6] but their 
sensitivity is limited to picomolar quantities. 
Reliable detection of femtomolar amounts of 
biotin using a solid-phase assay requires radioac- 
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tive biotin with a specific activity of at least 
1000 Ci/mmol. We found the cost of a commer- 
cially available 1251 iodinated derivative of biotin 
prohibitive for use in a routine assay. ‘251 labelling 
of biotin using the Bolton-Hunter reagent has also 
been described [4]. We describe an inexpensive, 
easily prepared biotin derivative labelled to high 
specific activity with Na’*‘I. This derivative in con- 
junction with immobilized streptavidin allows 
detection of as little as 1 fmol biotin, biotinylated 
protein or biotinylated nucleotide in solution. As 
examples of the application of this assay, the deter- 
mination of biotinylated insulin in a tissue extract 
and the quantitation of a transcription assay are 
given. 
2. MATERIALS AND METHODS 
2.1. Biotinylation 
Biotin N-hydroxysuccinimide ster (BNHS) was 
synthesized essentially according to May et al. [7]. 
From this biotinylglycyltyrosine was prepared as 
follows: 5 pmol glycyltyrosine (Sigma) was dis- 
solved in 200 ,uI dimethylformamide containing 
IO mM N-ethylmorpholine and added to 5 pmol 
BNHS in the same solution. The mixture was left 
to react at room temperature for 1 h and then sub- 
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jetted to high pressure liquid chromatography 
(HPLC) using a Millipore-Waters HPLC and a 
PBondapak C-18 Radial Pak column. A O-70% 
gradient of acetonitrile in 0.05% trifluoroacetic 
acid (TFA) was used for elution. 
N&t-hoc Glf’, NE t-hoc LysB2’ insulin (Diboc 
insulin), prepared according to Grant and Von 
Holt [B] was biotinylated using BNHS essentially 
according to the method of Hofmann et al. [9]. A 
small amount of [r4C]BNHS was included in the 
reaction to facilitate the identification of 
biotinylated insulin on the HPLC. The t-hoc 
groups were removed with anhydrous TFA and the 
product purified by HPLC using a O-70% gra- 
dient of acetonitrile in TFA as described before 
[8]. The degree of substitution of insulin with 
biotin was determined by the method of Swack et 
al. [5] using streptavidin-Sepharose and [14C]bio- 
tin. The molar ratio of biotin to insulin in the final 
product was 0.96 : 1. 5-(Allylamidobiotin)-UTP 
was synthesized according to Langer et al. [lo]. 
2.2. Radioiodination of biotinylglycyltyrosine 
(BGT) 
BGT was dissolved in 50 pl of 0.01 M phosphate 
buffer, pH 7.5, and iodinated with 1251 by incuba- 
tion with Na1251 (Amersham, 2000 Ci/mmol) in 
the presence of an Iodobead (Pierce). After in- 
cubation, unreacted iodine was removed by pass- 
ing the incubation mixture over a GlO column (0.5 
x 10 cm). Material eluting in the outer volume was 
concentrated and further fractionated by HPLC to 
remove noniodinated BGT (see section 3). 
2.3. Preparation and standardization of 
streptavidin-Sepharose 4B 
Streptavidin (Amersham) was linked to 
Sepharose 4B using CNBr-activated Sepharose 4B 
(Pharmacia). The number of biotin binding sites 
per microlitre suspension was determined using 
[carbonyl-14C]biotin (Amersham) of known 
specific activity. The specificity of binding of 
biotinylated compounds was checked in a competi- 
tion assay using unlabelled biotin. In order to 
facilitate the washing of the solid-phase strep- 
tavidin in the binding assay, underivatized 
Sepharose 4B can be added. 
2.4. Transcription 
A recombinant DNA molecule derived from the 
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sea urchin genome and the pUC derivative ‘Blue 
Scribe’ (Vector Cloning Systems) was transcribed 
using T7 RNA polymerase according to the instruc- 
tions supplied by Vector Cloning Systems. All 
nucleoside triphosphates were present at concen- 
trations of 0.4 mM. In experiments where UTP 
was replaced by 5-(allylamidobiotin)-UTP, the lat- 
ter was used at the same concentration. 15 &i 
[32P]GTP was added as indicated under results. 
After transcription 100 pg carrier RNA was added 
and the RNA precipitated with 10% trichloroacetic 
acid. The RNA precipitate was subjected to 
alkaline hydrolysis in 0.2 M KOH for 16 h at 
3O”C, neutralized and an aliquot assayed for 
biotinylated UTP. 
3. RESULTS AND DISCUSSION 
The biotinylglycyltyrosine was isolated by 
HPLC (fig.1). The product was freeze-dried and 
stored at -20°C and proved stable for at least 6 
months. The binding of BGT to streptavidin was 
indistinguishable from that of unmodified biotin 
as measured by fluorescence quenching (fig.2). 
After iodination of BGT and removal of un- 
bound 12’1, iodinated BGT was fractionated by 
HPLC (fig.3). The bulk of the radioactivity eluted 
as a single peak which was well separated from 
unlabelled BGT. The separation of the iodinated 
from the noniodinated compound is expected as a 
result of the hydrophobicity of the former. Over 
98% of radioactivity in this peak bound to 
streptavidin-Sepharose demonstrating the associa- 
tion of the biotinyl residue with the radioactivity. 
Iodination did not affect the binding of BGT to 
streptavidin (fig.2). To determine the specific ac- 
tivity of the iodinated BGT, the latter was quan- 
titated with streptavidin-Sepharose standardized 
with [14C]biotin of known specific activity. A 
single run on the HPLC routinely produced 12’1- 
labelled BGT with a specific activity equal to that 
of the input 1251 (1000-2000 Ci/mmol). BGT is 
thus a stable derivative of biotin which may be 
easily prepared from commercially available 
reagents and labelled to high specific activity with 
Na12?. 
The ‘251-labelled BGT was used in a solid-phase 
assay to determine small amounts of non- 
radioactive biotinylated compounds in solution in 
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Fig. 1. Fractionation of biotinylglycyltyrosine by HPLC. 
Solution A, 0.05% TFA; solution B, 70% acetonitrile in 
0.05% TFA. (---) @IO solution B, ( -) A230. To 
monitor the preparation and isolation of biotinyl- 
glycyltyrosine, [14C]biotin was added to some of the 
preparations and also as a marker in the final HPLC 
step. The shaded area represents the radioactive profile 
when [14C]biotin is used in the preparation. 
conjunction with a standardized preparation of 
streptavidin-Sepharose. To this end standardized 
streptavidin-Sepharose was reacted with the solu- 
tion containing the non-radioactive biotinylated 
compound (see also legend to fig.4). After washing 
the beads, an excess of labelled BGT was added to 
fill the unoccupied binding sites. The amount of 
the unknown was calculated from the difference in 
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Fig.2. Fluorescence quenching of streptavidin by biotin 
and BGT. On binding to biotin the fluorescence of the 
tryptophanyl residues in streptavidin is quenched [l]. 
3 ml of a 300~M solution of streptavidin in 0.01 M 
phosphate buffer, pH 7.5, were placed in a quartz 
cuvette and titrated with either biotin or biotin 
derivatives until no further quenching occurred [l]. 
Since micromolar quantities of biotin derivatives were 
used in the assay, iodinated BGT of a specific activity of 
0.1 mCi/mmol was prepared to avoid the use of large 
amounts of radioactivity in the assay. (-) Biotin, 
(---) BGT and iodinated BGT. 
binding of iodinated BGT prior to and after ex- 
posure of streptavidin-Sepharose to the solution 
containing the non-radioactive biotinylated com- 
pound. Biotinyl Phe-B 1 -insulin and biotinyiated 
UTP served as model compounds of widely dif- 
ferent molecular mass. Both of these compounds 
bound streptavidin-Sepharose in competition with 
BGT (fig.4). Neither could be displaced by a 
lOOO-fold excess of ‘251-BGT even after incubation 
for 3-4 h at room temperature. The linearity of 
competition extended to 95% saturation for 
biotinyl-UTP and 89% for biotinylinsulin (fig.4). 
As little as 1 fmol biotinylated insulin or UTP 
could be detected in solution (fig.4 and table 1). 
1 fmol biotin or biotinylated molecule corresponds 
to a decrease in the order of 3 x lo3 dpm “‘I- 
biotinylglycyltyrosine bound to the solid-phase 
streptavidin depending on the precise specific ac- 
tivity of the 1251-BGT. A 106-fold excess of un- 
biotinylated insulin had no effect on binding (table 
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Fig.3. Fractionation of 1251-labelled BGT by HPLC. 
Elution conditions as in fig. 1. (- - -) ‘70 solution B, 
(-) A230. Shaded black area: radioactivity (cpm). 
1). Nonspecific binding of i2?-BGT to 
streptavidin-Sepharose, was negligible (table 1). 
Vigorous and repeated washing of the streptavidin- 
Sepharose did not cause loss of bound material. 
Usually 3-4 washes sufficed to remove unbound 
BGT. Binding was not diminished in up to 5% of 
the nonionic detergent Triton X-100 (table 1). 
Biotinylated compounds extracted from tissues in 
0 I 2 3 
pmoles B-INS or B-UTP added 
Fig.4. Quantitation of biotinylinsulin and biotirlylated 
UTP binding to streptavidin-Sepharose at thrr picomolar 
level. Streptavidin-Sepharose containing 2 ;jmo: biotin 
binding sites (determined with [14C]PIoti!.) was 
incubated in 100 ~1 of 0.1 M phosphate buf!‘er, pH 7.5, 
with varying amounts of either biotinylinsulin or 
biotinylated UTP for 30 min at room temperature with 
shaking. Under these conditions 96% of binding 
occurred. Excess ‘251-BGT was added and incubated for 
30 min. The streptavidin-Sepharose was washed and 
counted. The bars represent the standard deviation. 
(- - -) Biotinylinsulin, (-) biotinylated UTP. 
the presence of this detergent may thus be assayed 
without the necessity of detergent removal. 
Streptavidin-Sepharose has been stored at 4’C for 
over 2 months without significant loss of binding 
activity. Re-standardization with [14C]biotin was 
however routinely performed. The 12’I-labelled 
BGT is stable for weeks at 4°C. 
In order to establish whether the assay would be 
useful for investigating the subcellular distribution 
of e.g. biotinylated proteins, biotinylinsulin was 
also assayed for in the presence of rat liver cytosol. 
50 fmol could be detected above the background 
(table 2) caused by the presence of available 
natural biotin. 
The assay has also been used to determine the in- 
corporation of biotinylated UTP into transcribed 
RNA (table 3). Transcription of DNA from Blue 
Scribe with T7-DNA-dependent RNA polymerase 
in the presence of biotinylated UTP, measured by 
[cY-~~P]GTP incorporation, was reduced by 50% 
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Table 1 Table 3 
Quantitation of femtomolar amounts of biotinylinsulin Assay for biotinyl-UTP incorporated into transcribed 
RNA 
Biotinylated insulin added 12? BGT bound 
(fmol) (cpm) 
0 29800 i 1910 
1 27220 f 1720 
5 15820 f 1260 
10 4180 + 652 
10 (after preincubation of 
streptavidin-Sepharose with 
5 nmol biotin) 320 f 96 
5 (+ 5 nmol unlabelled insulin) 14760 f 1162 
5 (in 5% Triton X-100) 16210 f 1210 
Streptavidin-Sepharose with 10 fmol biotin binding sites 
was incubated with various amounts of biotinylated 
insulin for 1 h in a total volume of 20 ~1 with shaking. 
Sepharose 4B was present as carrier. Under these 
conditions 84% binding of biotinylinsulin could be 
achieved. After incubation, 1 pCi of “‘1 BGT 
(1500 Ci/mmol) was added and incubation continued 
for 30 min. The streptavidin-Sepharose was washed with 
0.1 M NaCI, 0.01 M Na phosphate, pH 7.5, until the 
supernatant contained less than 1% of the counts in the 
pellet. Results represent the average of at least 3 





Control UTP re- Biotinyl- 
placed by UTP 
biotinylated incorporated 
UTP 
0 2786 923 0.72 
10 15092 6520 28.64 
(table 3) similar to results from other laboratories 
[IO]. Given the specific activity of “‘I- 
biotinylglycyltyrosine, incorporation of fem- 
tomolar amounts of biotinyl-UTP can be 
measured. The assay should also be applicable to 
biotinylated RNA or DNA probes and offers an 
alternative to the detection of biotinylated RNA 
and DNA after immobilization on nitrocellulose. 
For the preparation of biotinylated hybridization 
probes, longer linker groups between UTP and the 
biotinyl residue are required [ 111. 
Table 2 
Detection of biotinylated insulin in rat liver cytosol 
Biotinylinsulin 
added (fmol) 
12’1 BGT bound Biotinyl- 
(cpm x 10m3) insulin 
recovery 
(fmol) 
0 (no cytosol present) 3120 f 125 
0 (+ 100 fll cytosol) 2062 Ifr 77 
50 1922 f 61 47 
100 1748 f 48 101 
200 1486 f 47 187 
700 148 f 21 653 
Rat liver cytosol was isolated according to Smith and 
Von Holt [ 121. Streptavidin-Sepharose containing 
1 pmol biotin binding sites was incubated with 100 ,uI of 
a cytosol preparation (2 mg liver tissue), plus increasing 
amounts of biotinylinsulin for 1 h at 4°C. After 
incubation, 1 /tCi of 12’1 BGT was added and the 
procedure followed as described in the legend to table 1. 
Results represent the average of three determinations 
This assay to quantitate in the femto-picomolar 
range, biotinylated compounds, including proteins 
and nucleotides, in solution lends itself to the in- 
vestigation of the intracellular distribution and the 
binding of e.g. peptide hormones and other com- 
pounds to subcellular structures. The sensitivity of 
the assay is comparable to that achieved when pro- 
teins are labelled with carrier free iodine. The assay 
therefore makes biotin a useful alternative label 
for the investigation of molecules which either lose 
their biological activity when iodinated or lack an 
aromatic residue as substrate for iodination. The 
assay will also allow the determination of the 
specific activities of biotinylated RNA and DNA 
probes. 
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